Prognostic effect of early treatment of paraneoplastic limbic encephalitis in a patient with small-cell lung cancer

Current Oncology

Volumn 19, Issue 5, 2012, Pages

  Lalani, Nafisha ^a,b   Haq, R ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Limbic encephalitis; Paraneoplastic; Small cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DONEPEZIL; ETOPOSIDE; GABAPENTIN; HU ANTIBODY; IMMUNOGLOBULIN; NARCOTIC ANALGESIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ANTIBODY BLOOD LEVEL; ARTICLE; ATAXIA; BRAIN ISCHEMIA; CANCER PROGNOSIS; CANCER SURVIVAL; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; COGNITIVE THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISTAL PARESTHESIA; DYSARTHRIA; EARLY DIAGNOSIS; EARLY INTERVENTION; ELECTROMYOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; HEADACHE; HUMAN; KINESIOTHERAPY; LUMBAR PUNCTURE; LUNG SMALL CELL CANCER; MALE; MEMORY DISORDER; MOOD CHANGE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; PAPILLEDEMA; PARANEOPLASTIC NEUROPATHY; POLYRADICULONEUROPATHY; PROTEIN CEREBROSPINAL FLUID LEVEL; RISK BENEFIT ANALYSIS; SMOKING; SURVIVAL RATE; TREATMENT REFUSAL; TUMOR BIOPSY; VISUAL DISORDER;

EID: 84867095474     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.19.1007     Document Type: Article

References (10)

1. Honnorat J, Antoine JC. Paraneoplastic neurological syndromes. Orphanet J Rare Dis 2007;2:22.
2. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-40.
3. Graus F, Dalmou J, Reñé R, et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 1997;15:2866-72.
4. Vedeler CA, Antoine JC, Giometto B, et al. on behalf of Paraneoplastic Neurological Syndrome Euronetwork. Management of paraneoplastic neurological syndromes: report of an efns Task Force. Eur J Neurol 2006;13:682-90.
5. Tüzün E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 2007;13:261-71.
6. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;123:1481-94.
7. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine (Baltimore) 1992;71:59-72.
8. Senties-Madrid H, Vega-Boada F. Paraneoplastic syndromes associated with anti-Hu antibodies. Isr Med Assoc J 2001;3:94-103.
9. Alamowitch S, Graus F, Uchuya M, Reñé R, Bescansa E, Delattre JY. Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain 1997;120:923-8.
10. Sculier JP, Chansky K, Crowley JJ, Van Meerbeeck J, Goldstraw P on behalf of the International Staging Committee and Participating Institutions. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM Classification of Malignant Tumors and the proposals for the 7th edition. J Thorac Oncol 2008;3:457-66.